Literature DB >> 26974599

Investigation of the Binding Interaction of Fatty Acids with Human G Protein-Coupled Receptor 40 Using a Site-Specific Fluorescence Probe by Flow Cytometry.

Xiao-Min Ren1, Lin-Ying Cao1, Jing Zhang1, Wei-Ping Qin2, Yu Yang1, Bin Wan1, Liang-Hong Guo1,3.   

Abstract

Human G protein-coupled receptor 40 (hGPR40), with medium- and long-chain free fatty acids (FFAs) as its natural ligands, plays an important role in the enhancement of glucose-dependent insulin secretion. To date, information about the direct binding of FFAs to hGPR40 is very limited, and how carbon-chain length affects the activities of FFAs on hGPR40 is not yet understood. In this study, a fluorescein-fasiglifam analogue (F-TAK-875A) conjugate was designed and synthesized as a site-specific fluorescence probe to study the interaction of FFAs with hGPR40. hGPR40 was expressed in human embryonic kidney 293 cells and labeled with F-TAK-875A. By using flow cytometry, competitive binding of FFA and F-TAK-875A to hGPR40-expressed cells was measured. Binding affinities of 18 saturated FFAs, with carbon-chain lengths ranging from C6 to C23, were analyzed. The results showed that the binding potencies of FFAs to hGPR40 were dependent on carbon length. There was a positive correlation between length and binding potency for seven FFAs (C9-C15), with myristic acid (C15) showing the highest potency, 0.2% relative to TAK-875. For FFAs with a length of fewer than C9 or more than C15, they had very weak or no binding. Molecular docking results showed that the binding pocket of TAK-875 in hGPR40 could enclose FFAs with lengths of C15 or fewer. However, for FFAs with lengths longer than C15, part of the alkyl chain extended out of the binding pocket. This study provided insights into the structural dependence of FFAs binding to and activation of hGPR40.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974599     DOI: 10.1021/acs.biochem.6b00079

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Toward molecular imaging of the free fatty acid receptor 1.

Authors:  Ewa Hellström-Lindahl; Ola Åberg; Cecilia Ericsson; Gavin O'Mahony; Peter Johnström; Stanko Skrtic; Olof Eriksson
Journal:  Acta Diabetol       Date:  2017-04-13       Impact factor: 4.280

2.  Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.

Authors:  Yujin Lee; Heidi T M Lai; Marcia C de Oliveira Otto; Rozenn N Lemaitre; Barbara McKnight; Irena B King; Xiaoling Song; Gordon S Huggins; Amanda R Vest; David S Siscovick; Dariush Mozaffarian
Journal:  J Am Heart Assoc       Date:  2020-02-05       Impact factor: 5.501

3.  In-Vivo Antidiabetic Activity and In-Silico Mode of Action of LC/MS-MS Identified Flavonoids in Oleaster Leaves.

Authors:  Hamza Mechchate; Imane Es-Safi; Mohammed Bourhia; Andrii Kyrylchuk; Abdelfattah El Moussaoui; Raffaele Conte; Riaz Ullah; Essam Ezzeldin; Gamal A Mostafa; Andriy Grafov; Hicham Bekkari; Dalila Bousta
Journal:  Molecules       Date:  2020-11-01       Impact factor: 4.411

Review 4.  Dairy Fat Consumption and the Risk of Metabolic Syndrome: An Examination of the Saturated Fatty Acids in Dairy.

Authors:  Allison L Unger; Moises Torres-Gonzalez; Jana Kraft
Journal:  Nutrients       Date:  2019-09-12       Impact factor: 5.717

5.  Insight into Gentisic Acid Antidiabetic Potential Using In Vitro and In Silico Approaches.

Authors:  Hamza Mechchate; Imane Es-Safi; Omkulthom Mohamed Al Kamaly; Dalila Bousta
Journal:  Molecules       Date:  2021-03-30       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.